Skip to content

The AMD Experts

50196296_795957517416981_458178117475762176_n

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

The AdaptDx is especially useful for optometrists and general ophthalmologists who see many patients with “normal” clinical exams, since it can detect subclinical AMD up to three years before clinical onset. With the AdaptDx, you will be in the front line in detecting these patients and will be able to carefully monitor and treat those with subclinical AMD.

Dr. Shawn Lewis1 Shawn Lewis, MD View all testimonials

Latest News & Upcoming Events

View More
Article: November 18, 2019 | Women in Optometry

How Passion Helped Build a Thriving Medical Practice

Dr. Jessica Marshall has succeeded in doubling her eye care practice's bottom line, thanks to her strong commitment to medical services and a recent focus on AMD.

Article: November 1, 2019 | Optometric Management

Four Ways to Help Staff Embrace New Technology

An important thing to recognize when purchasing new technology is that it’s not enough for optometrists to believe in what an instrument can do for their patients. Their staff must believe it too! By Dr. Timothy Earley and Dr. Laurie Sorrenson.

Our Blog: October 10, 2019

Patient Education: Trouble Seeing at Night is a Telltale Sign of Age-Related Macular Degeneration

Anne-Marie Lahr, OD reveals how your retinal function may tell us more than we can see in a clinical exam.

Put Our Expertise to Work

Testing with AdaptDx

AdaptDx identifies impaired dark adaptation—the earliest warning sign of AMD.

Guiding AdaptDx Implementation

Each AdaptDx purchase is supported by our AMD Excellence Program™ to help you achieve your patient care and practice revenue goals.